Postoperative Analgesic Efficacy of Tetracaine Hydrochloride Gel
- Registration Number
- NCT02863679
- Lead Sponsor
- Wenzhou Medical University
- Brief Summary
This study was taken out to assess the postoperative analgesic efficacy of tetracaine hydrochloride gel in patients with intrauterine adhesion treating with intrauterine balloon.Participates were assigned into two groups by randomly-tetracaine hydrochloride gel group and control group.
- Detailed Description
Tetracaine hydrochloride gel contains 1% tetracaine hydrochloride, and a fair dose of fungicide, lubricants, remove foam agent, as the long-term local anesthetics. Patients in getracaine hydrochloride gel group were covered with a gauze of tetracaine hydrochloride gel on the external cervical orifice after insert an utrauterine balloon in the uterine cavity. While patients in the control group were covered with a blank gauze after hysteroscopic adhesiolysis. Compare the postoperative analgesic scor and patients' analgesic satisfaction of the two groups and asess the analgesic efficacy of tetracaine hydrochloride gel.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 84
- no previous history of hysteroscopic adhesiolysis or surgery on the cervix
- inserted intrauterine balloon in the uterine cavity after hysteroscopic adhesiolysis
- no other diseases
- Allergy to local anesthetics
- Patients with chronic pain
- Patients with abnormal blood coagulation function
- Patients with mental illness that can not cooperate
- Patients with previous hysteroscopic adhesiolysis or cervical surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tetracaine hydrochloride gel group Tetracaine hydrochloride gel Patients in getracaine hydrochloride gel group were covered with a gauze with tetracaine hydrochloride gel on the cervix after hysteroscopic insertion of utrauterine balloon stent. Control group Tetracaine hydrochloride gel Patients in control group were covered with a gauze with saline on the cervix after hysteroscopic insertion of utrauterine balloon stent.
- Primary Outcome Measures
Name Time Method Numerical Rating Scale (NRS) score 7 days
- Secondary Outcome Measures
Name Time Method patients received balloon volume reduction 1 day
Trial Locations
- Locations (1)
the 1st Affiliated Hospital of Wenzhou Medical College
🇨🇳Wenzhou, Zhejiang, China